Methyl salicylate 2-O-β-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Lan, Xi ^a   Liu, Rui ^a   Sun, Lan ^a   Zhang, Tiantai ^a   Du, Guanhua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DL 0309; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; METHYLSALICYLATE 2 O BETA DEXTRO LACTOSIDE; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; SALICYLIC ACID DERIVATIVE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; GLYCOSIDE; LACTOSIDES; SALICYLIC ACID;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME REGULATION; MICROGLIA; NERVE CELL STIMULATION; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ALZHEIMER DISEASE; ANIMAL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLYCOSIDES; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICROGLIA; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; SALICYLIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051486853     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-98     Document Type: Article

References (21)

1. Maragakis NJ, Rothstein JD. Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006, 2:679-689.
2. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 2003, 9:453-457. 10.1038/nm838, 12612547.
3. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 2006, 12:1005-1015.
4. Benveniste EN. Cytokines: influence on glial cell gene expression and function. Chem Immunol 1997, 69:31-75.
5. Streit WJ, Sammons NW, Kuhns AJ, Sparks DL. Dystrophic microglia in the aging human brain. Glia 2004, 45:208-212. 10.1002/glia.10319, 14730714.
6. Allaman I, Belanger M, Magistretti PJ. Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 2011, 34:76-87. 10.1016/j.tins.2010.12.001, 21236501.
7. Pinnen F, Sozio P, Cacciatore I, Cornacchia C, Mollica A, Iannitelli DAE, Cataldi A, Zara S, Nasuti C, Di Stefano A. Ibuprofen and Glutathione Conjugate as a Potential Therapeutic Agent for Treating Alzheimer's Disease. Arch Pharm (Weinheim) 2010,
8. Ray B, Lahiri DK. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. Curr Opin Pharmacol 2009, 9:434-444. 10.1016/j.coph.2009.06.012, 19656726.
9. Zhang D, Liu R, Sun L, Huang C, Wang C, Zhang DM, Zhang TT, Du GH. Anti-inflammatory activity of methyl salicylate glycosides isolated from Gaultheria yunnanensis (Franch.) Rehder. Molecules 2011, 16:3875-3884. 10.3390/molecules16053875, 21555977.
10. Zhang B, He XL, Ding Y, Du GH. Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: towards a better non-steroidal anti-inflammatory drug. Eur J Pharmacol 2006, 530:166-171. 10.1016/j.ejphar.2005.11.030, 16375889.
11. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980, 85:890-902. 10.1083/jcb.85.3.890, 2111442, 6248568.
12. Drew PD, Chavis JA. The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. J Neuroimmunol 2001, 115:28-35. 10.1016/S0165-5728(01)00267-3, 11282151.
13. Fiebich BL, Lieb K, Kammerer N, Hull M. Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia. J Neurochem 2003, 86:173-178.
14. Candelario-Jalil E, de Oliveira AC, Graf S, Bhatia HS, Hull M, Munoz E, Fiebich BL. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflammation 2007, 4:25. 10.1186/1742-2094-4-25, 2100038, 17927823.
15. Akundi RS, Candelario-Jalil E, Hess S, Hull M, Lieb K, Gebicke-Haerter PJ, Fiebich BL. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 2005, 51:199-208. 10.1002/glia.20198, 15800925.
16. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005, 202:145-156. 10.1084/jem.20041918, 2212896, 15998793.
17. Thomas T, Nadackal TG, Thomas K. Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation. Neuroreport 2001, 12:3263-3267. 10.1097/00001756-200110290-00024, 11711868.
18. Cornelius C, Fastbom J, Winblad B, Viitanen M. Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology 2004, 23:35-143.
19. Iwata Y, Nicole O, Zurakowski D, Okamura T, Jonas RA. Ibuprofen for neuroprotection after cerebral ischemia. J Thorac Cardiovasc Surg 2010, 139:489-493. 10.1016/j.jtcvs.2009.05.049, 2850810, 19853865.
20. Zandi PP, Breitner JC, Anthony JC. Is pharmacological prevention of Alzheimer's a realistic goal?. Expert Opin Pharmacother 2002, 3:365-380. 10.1517/14656566.3.4.365, 11934339.
21. Ferrera P, Arias C. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells. Neurochem Int 2005, 47:589-596. 10.1016/j.neuint.2005.06.012, 16169124.